| Activation of innate immune antiviral responses by Nod2 A Sabbah, TH Chang, R Harnack, V Frohlich, K Tominaga, PH Dube, ... Nature immunology 10 (10), 1073-1080, 2009 | 913 | 2009 |
| An assembly domain of the Rous sarcoma virus Gag protein required late in budding JW Wills, CE Cameron, CB Wilson, Y Xiang, RP Bennett, J Leis Journal of virology 68 (10), 6605-6618, 1994 | 340 | 1994 |
| Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L MD Sacco, C Ma, P Lagarias, A Gao, JA Townsend, X Meng, P Dube, ... Science Advances 6 (50), eabe0751, 2020 | 338 | 2020 |
| Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells A Kikonyogo, F Bouamr, ML Vana, Y Xiang, A Aiyar, C Carter, J Leis Proceedings of the National Academy of Sciences 98 (20), 11199-11204, 2001 | 266 | 2001 |
| IL-18 binding and inhibition of interferon γ induction by human poxvirus-encoded proteins Y Xiang, B Moss Proceedings of the National Academy of Sciences 96 (20), 11537-11542, 1999 | 258 | 1999 |
| Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain Y Xiang, CE Cameron, JW Wills, J Leis Journal of virology 70 (8), 5695-5700, 1996 | 209 | 1996 |
| Site-directed mutagenesis using overlap extension PCR A Aiyar, Y Xiang, J Leis In vitro mutagenesis protocols, 177-191, 1996 | 204 | 1996 |
| Role of human β-defensin-2 during tumor necrosis factor-α/NF-κB-mediated innate antiviral response against human respiratory syncytial virus S Kota, A Sabbah, R Harnack, Y Xiang, X Meng, S Bose Journal of biological chemistry 283 (33), 22417-22429, 2008 | 188 | 2008 |
| The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor Y Hu, X Meng, F Zhang, Y Xiang, J Wang Emerging microbes & infections 10 (1), 317-330, 2021 | 154 | 2021 |
| Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters Y Xiang, A White Emerging microbes & infections 11 (1), 1768-1777, 2022 | 140 | 2022 |
| Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and a FlipGFP-based reporter assay C Ma, MD Sacco, Z Xia, G Lambrinidis, JA Townsend, Y Hu, X Meng, ... ACS central science 7 (7), 1245-1260, 2021 | 124 | 2021 |
| Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors N Kitamura, MD Sacco, C Ma, Y Hu, JA Townsend, X Meng, F Zhang, ... Journal of medicinal chemistry 65 (4), 2848-2865, 2021 | 120 | 2021 |
| Structural biology of the IL‐1 superfamily: Key cytokines in the regulation of immune and inflammatory responses B Krumm, Y Xiang, J Deng Protein Science 23 (5), 526-538, 2014 | 105 | 2014 |
| Discovery of di-and trihaloacetamides as covalent SARS-CoV-2 main protease inhibitors with high target specificity C Ma, Z Xia, MD Sacco, Y Hu, JA Townsend, X Meng, J Choza, H Tan, ... Journal of the American Chemical Society 143 (49), 20697-20709, 2021 | 101 | 2021 |
| Orthopoxvirus IL-18 binding proteins: affinities and antagonist activities S Calderara, Y Xiang, B Moss Virology 279 (1), 22-26, 2001 | 91 | 2001 |
| Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein B Krumm, X Meng, Y Li, Y Xiang, J Deng Proceedings of the National Academy of Sciences 105 (52), 20711-20715, 2008 | 85 | 2008 |
| Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins Y Xiang, B Moss Journal of Virology 75 (20), 9947-9954, 2001 | 82 | 2001 |
| Vaccinia virus K1L and C7L inhibit antiviral activities induced by type I interferons X Meng, C Jiang, J Arsenio, K Dick, J Cao, Y Xiang Journal of virology 83 (20), 10627-10636, 2009 | 80 | 2009 |
| Using a combined computational-experimental approach to predict antibody-specific B cell epitopes I Sela-Culang, MREI Benhnia, MH Matho, T Kaever, M Maybeno, ... Structure 22 (4), 646-657, 2014 | 78 | 2014 |
| Rational design of hybrid SARS-CoV-2 main protease inhibitors guided by the superimposed cocrystal structures with the peptidomimetic inhibitors GC-376, telaprevir, and boceprevir Z Xia, M Sacco, Y Hu, C Ma, X Meng, F Zhang, T Szeto, Y Xiang, Y Chen, ... ACS Pharmacology & Translational Science 4 (4), 1408-1421, 2021 | 76 | 2021 |
